The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and performance results from PATHFINDER 2, a registrational study of a multi-cancer early detection (MCED) test in an intended-use population.
 
Karthik Giridhar
Consulting or Advisory Role - Association for Molecular Pathology; AstraZeneca/Daiichi Sankyo (Inst); Clinical Care Solutions; Conexiant; GRAIL; Lilly (Inst); Medscape; Novartis; Primo Summit; Puma Biotechnology (Inst); Quantum Leap Healthcare Collaborative
Research Funding - Guardant Health (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - GRAIL; QuantumLeap Health
 
Charles McDonnell
Consulting or Advisory Role - Grail
 
Dax Kurbegov
Employment - HCA Healthcare
Stock and Other Ownership Interests - HCA Healthcare
Research Funding - Exact Sciences (Inst); GRAIL (Inst); Harbinger Health (Inst); Roche/Genentech (Inst)
 
Marc Matrana
Employment - Ochsner Health; Ochsner Health System (I)
Consulting or Advisory Role - AstraZeneca; Tempus
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Eisai; Exelixis; Genentech; Janssen; Merck; Seagen
 
Shirish Gadgeel
Consulting or Advisory Role - Abbvie; Arcus Biosciences; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daichii-Sanyko; Eisai; Genentech/Roche; Gilead Sciences; Gilead Sciences; Johnson & Johnson/Janssen; Lilly; Merck; Mirati Therapeutics; Pfizer; Regeneron; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); Arcus Biosciences (Inst); ArriVent Biopharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Avistone Biotechnology (Inst); Bayer (Inst); D3 Bio (Inst); Daiichi Sankyo (Inst); Debiopharm Group (Inst); eFFECTOR Therapeutics (Inst); Genentech/Roche (Inst); Genmab (Inst); GRAIL (Inst); Helsinn Therapeutics (Inst); Incyte (Inst); InventisBio (Inst); Iovance Biotherapeutics (Inst); Jacobio (Inst); Janssen Oncology (Inst); Janux Therapeutics (Inst); Kymera (Inst); Merck (Inst); Mirati Therapeutics (Inst); Monte Rosa Therapeutics (Inst); Nimbus Therapeutics (Inst); Novita Pharmaceuticals (Inst); Numab (Inst); Nuvalent, Inc. (Inst); Pfizer (Inst); Regeneron (Inst); Revolution Medicines (Inst); Tango Therapeutics (Inst); Turning Point Therapeutics (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Merck; Mirati Therapeutics
Other Relationship - AstraZeneca
 
Raymond Kim
No Relationships to Disclose
 
Gretchen Stipec
No Relationships to Disclose
 
Kevin Oeffinger
Leadership - Maia Oncology, Inc
Stock and Other Ownership Interests - Maia Oncology, Inc
Consulting or Advisory Role - Maia Oncology, Inc
Research Funding - GRAIL (Inst)
 
Michael Demeure
Stock and Other Ownership Interests - Agenus
Honoraria - AADi; Corcept Therapeutics; Crinetics Pharmaceuticals; Loxo/Lilly; White hawk Therapeutics
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Crinetics Pharmaceuticals; Loxo/Lilly; OnCusp Therapeutics; Orphagen Pharmaceuticals; Pfizer; TD2; Theralink
(OPTIONAL) Uncompensated Relationships - transmed7
 
James Lillard
Patents, Royalties, Other Intellectual Property - Chinook Therapeutics (a Novartis compan
 
Rebecca Kaltman
Employment - Biomarin (I); Cytokinetics (I)
Stock and Other Ownership Interests - Biomarin (I); Cytokinetics (I); Previvor Edge
Consulting or Advisory Role - Previvor Edge
Research Funding - Grail (Inst); Northrup Grumman (Inst)
(OPTIONAL) Uncompensated Relationships - Canfield (Inst); ClearNote Health (Inst); Exact Sciences (Inst); Prenuvo (Inst); UDS (United Diagnostic Services) (Inst)
 
Jennifer Tran
Stock and Other Ownership Interests - Novo Nordisk; Vertex
 
Alan Roth
No Relationships to Disclose
 
Sami Tahhan
No Relationships to Disclose
 
Andrew Poklepovic
Consulting or Advisory Role - IO Biotech
Speakers' Bureau - Natera
 
Donald Richards
Consulting or Advisory Role - Grail; Ipsen; Mirati Therapeutics; Roche/Genentech; Seattle Genetics/Astellas; Taiho Pharmaceutical
 
Rita Lopatin
Employment - GRAIL
Stock and Other Ownership Interests - GRAIL; Illumina
 
Celine Marquez
Employment - Genentech; GRAIL
Stock and Other Ownership Interests - Genentech; GRAIL,Inc.
 
Margaret McCusker
Employment - GRAIL
Stock and Other Ownership Interests - GRAIL; Illumina; Roche
 
Nima Nabavizadeh
Honoraria - GRAIL; MJH Life Sciences; Roche
Consulting or Advisory Role - GRAIL